241 related articles for article (PubMed ID: 17408366)
1. Potential of active and passive immunizations for the prevention and therapy of transmissible spongiform encephalopathies.
Bade S; Frey A
Expert Rev Vaccines; 2007 Apr; 6(2):153-68. PubMed ID: 17408366
[TBL] [Abstract][Full Text] [Related]
2. Cell culture models of transmissible spongiform encephalopathies.
Béranger F; Mangé A; Solassol J; Lehmann S
Biochem Biophys Res Commun; 2001 Nov; 289(2):311-6. PubMed ID: 11716473
[TBL] [Abstract][Full Text] [Related]
3. Prion protein-specific antibodies for therapeutic intervention of transmissible spongiform encephalopathies.
Buchholz CJ; Bach P; Nikles D; Kalinke U
Expert Opin Biol Ther; 2006 Mar; 6(3):293-300. PubMed ID: 16503737
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapeutic effect of anti-PrP monoclonal antibodies in transmissible spongiform encephalopathy mouse models: pharmacokinetic and pharmacodynamic analysis.
Féraudet-Tarisse C; Andréoletti O; Morel N; Simon S; Lacroux C; Mathey J; Lamourette P; Relaño A; Torres JM; Créminon C; Grassi J
J Gen Virol; 2010 Jun; 91(Pt 6):1635-45. PubMed ID: 20107012
[TBL] [Abstract][Full Text] [Related]
5. Curative properties of antibodies against prion protein: a comparative in vitro study of monovalent fragments and divalent antibodies.
Alexandrenne C; Hanoux V; Dkhissi F; Boquet D; Couraud JY; Wijkhuisen A
J Neuroimmunol; 2009 Apr; 209(1-2):50-6. PubMed ID: 19232746
[TBL] [Abstract][Full Text] [Related]
6. Vaccination with prion peptide-displaying papillomavirus-like particles induces autoantibodies to normal prion protein that interfere with pathologic prion protein production in infected cells.
Handisurya A; Gilch S; Winter D; Shafti-Keramat S; Maurer D; Schätzl HM; Kirnbauer R
FEBS J; 2007 Apr; 274(7):1747-58. PubMed ID: 17313482
[TBL] [Abstract][Full Text] [Related]
7. Human and animal spongiform encephalopathies are autoimmune diseases: a novel theory and its supporting evidence.
Zhu BT
Int Rev Neurobiol; 2005; 63():155-90. PubMed ID: 15797468
[No Abstract] [Full Text] [Related]
8. Is vaccination against transmissible spongiform encephalopathy feasible?
Wisniewski T; Chabalgoity JA; Goni F
Rev Sci Tech; 2007 Apr; 26(1):243-51. PubMed ID: 17633306
[TBL] [Abstract][Full Text] [Related]
9. Recent developments in prion immunotherapy.
Heppner FL; Aguzzi A
Curr Opin Immunol; 2004 Oct; 16(5):594-8. PubMed ID: 15342005
[TBL] [Abstract][Full Text] [Related]
10. Anti-prion antibodies for prophylaxis following prion exposure in mice.
Sigurdsson EM; Sy MS; Li R; Scholtzova H; Kascsak RJ; Kascsak R; Carp R; Meeker HC; Frangione B; Wisniewski T
Neurosci Lett; 2003 Jan; 336(3):185-7. PubMed ID: 12505623
[TBL] [Abstract][Full Text] [Related]
11. Diagnostics for TSE agents.
Raeber AJ; Oesch B
Dev Biol (Basel); 2006; 123():313-23; discussion 349-54. PubMed ID: 16566455
[TBL] [Abstract][Full Text] [Related]
12. Development of antibody fragments for immunotherapy of prion diseases.
Campana V; Zentilin L; Mirabile I; Kranjc A; Casanova P; Giacca M; Prusiner SB; Legname G; Zurzolo C
Biochem J; 2009 Mar; 418(3):507-15. PubMed ID: 19000036
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody F89/160.1.5 defines a conserved epitope on the ruminant prion protein.
O'Rourke KI; Baszler TV; Miller JM; Spraker TR; Sadler-Riggleman I; Knowles DP
J Clin Microbiol; 1998 Jun; 36(6):1750-5. PubMed ID: 9620413
[TBL] [Abstract][Full Text] [Related]
14. Vaccination against prion diseases.
Kalinke U; Bach P; König M; Buchholz CJ
Discov Med; 2006 Feb; 6(31):29-34. PubMed ID: 17234125
[TBL] [Abstract][Full Text] [Related]
15. Human and animal spongiform encephalopathies are the result of chronic autoimmune attack in the CNS: a novel medical theory supported by overwhelming experimental evidence.
Zhu BT
Histol Histopathol; 2005 Apr; 20(2):575-92. PubMed ID: 15736062
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy for prion diseases: opportunities and obstacles.
Li L; Napper S; Cashman NR
Immunotherapy; 2010 Mar; 2(2):269-82. PubMed ID: 20635933
[TBL] [Abstract][Full Text] [Related]
17. Vaccine approaches to prevent and treat prion infection : progress and challenges.
Müller-Schiffmann A; Korth C
BioDrugs; 2008; 22(1):45-52. PubMed ID: 18215090
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic approaches targeting the prion receptor LRP/LR.
Zuber C; Ludewigs H; Weiss S
Vet Microbiol; 2007 Aug; 123(4):387-93. PubMed ID: 17498894
[TBL] [Abstract][Full Text] [Related]
19. Interventional strategies against prion diseases.
Aguzzi A; Glatzel M; Montrasio F; Prinz M; Heppner FL
Nat Rev Neurosci; 2001 Oct; 2(10):745-9. PubMed ID: 11584312
[TBL] [Abstract][Full Text] [Related]
20. Prions: protein aggregation and infectious diseases.
Aguzzi A; Calella AM
Physiol Rev; 2009 Oct; 89(4):1105-52. PubMed ID: 19789378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
